发明名称 HYPOXIA-INDUCED MITOGENIC FACTOR
摘要 We found that FIZZ1/RELMα is inducible by hypoxia in lung. The hypoxia-upregulated expression of FIZZ1/RELMα was located in the pulmonary vasculature, bronchial epithelial cells, and type II pneumocytes. Recombinant FIZZ1/RELMα protein stimulates rat pulmonary microvascular smooth muscle cell (RPSM) proliferation dose-dependently. Therefore, we renamed this gene as hypoxia-induced mitogenic factor (HIMF). HIMF strongly activated Akt phosphorylation. The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 inhibits HIMF-activated Akt phosphorylation. It also inhibits HIMF-stimulated RPSM proliferation. Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative effect of HIMF. HIMF also has angiogenic and vasoconstrictive activity. Notably, HIMF increases pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II.
申请公布号 US2015004172(A1) 申请公布日期 2015.01.01
申请号 US201414482398 申请日期 2014.09.10
申请人 The Johns Hopkins University 发明人 Johns Roger;Teng Xingwu;Li Dechun
分类号 C07K16/18 主分类号 C07K16/18
代理机构 代理人
主权项 1. A method of treating a patient with pulmonary hypertension, comprising: administering to the patient an antibody which specifically binds to a protein comprising the sequence of SEQ ID NO: 1, in an amount sufficient to reduce the extent of pulmonary vasoconstriction.
地址 Baltimore MD US